Clinical Care Considerations for COVID-19 Vaccination

COVID-19 vaccine recommendations have been updated as of September 12. The content on this page is no longer current and will be updated to align with the new recommendations. Learn more.

The Advisory Committee on Immunization Practices (ACIP) has issued interim recommendations for the use of Pfizer-BioNTech, Moderna, ​and Janssen/Johnson & Johnson COVID-19 vaccines for the prevention of coronavirus disease 2019 (COVID-19) in the United States. You can find these recommendations as well as clinical considerations for managing adverse events below.

Use of COVID-19 Vaccines

Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States.

Specific Clinical Considerations
Severe Allergic Reactions
Vaccinating Special Populations